Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
British Heart Journal|June 1, 1990
Importance of reciprocal ST segment depression in leads V5 and V6 as an indicator of disease of the left anterior descending coronary artery in acute inferior wall myocardial infarctionB Strasberg, A Pinchas, G I Barbash, et al.The American Journal of Cardiology|February 1, 1991
Prognostic importance of delayed Q-wave evolution 3 to 24 hours after initiation of thrombolytic therapy for acute myocardial infarctionM J Eisenberg, G I Barbash, H Hod, et al.Journal of the American College of Cardiology|April 1, 1990
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot studyA Roth, G I Barbash, H Hod, et al.The American Journal of Cardiology|September 1, 1990
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarctionG I Barbash, A Roth, H Hod, et al.The American Journal of Cardiology|August 1, 1990
Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarctionG I Barbash, A Roth, H Hod, et al.British Heart Journal|October 1, 1990
Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial InfarctionG I Barbash, A Roth, H Hod, et al.American Heart Journal|May 29, 2001
Prediction of the extent and severity of left ventricular dysfunction in anterior acute myocardial infarction by the admission electrocardiogramY Birnbaum, D A Criger, G S Wagner, et al.The American Journal of Cardiology|December 1, 1989
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarctionG I Barbash, H Hod, A Roth, et al.Circulation|November 1, 1993
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality StudyH D White, G I Barbash, M Modan, et al.Journal of the American College of Cardiology|October 1, 1990
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemiaG I Barbash, H Hod, A Roth, et al.Pageof 5